Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
ROCKET PHARMACEUTICALS, INC. (RCKT)
Sector: Healthcare; Industry: Biotechnology

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It also has additional infantile malignant osteopetrosis, a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption. In addition, the company has an adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. Rocket Pharmaceuticals, Inc. is headquartered in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-12-13 SOUTHWELL DAVID P Director Sell 38,768 $15.19 $588,886 No
2018-12-07 SOUTHWELL DAVID P Director Sell 57,732 $15.13 $873,458 Yes
2017-01-06 SOUTHWELL DAVID P President and CEO Buy 60,000 $1.75 $105,000 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.